In the present study, CyclinD1 was targeted by six deregulated miRNAs that regulated pathways in cancer and were reduced in expression–that is, let-7g and -7i, and miR-195, -424, -503, and -93–suggesting that this could underlie the increased levels of CyclinD1. The gene discussed is CCND1; the disease is cancer.